A previous investigation demonstrated that the molecular mechanism underlying the impact of Leigongjiang polysaccharide on CRC involves the downregulation of IncRNA PRR34-AS1 expression and modulation of the downstream Foxo3a/Wnt/β-catenin pathway (Mou and Shu, 2023). The gene discussed is FOXO3; the disease is colorectal carcinoma.